I don't think the FDA will consider the one extendered mouse trial, (12 day mouse trial No 2) to be enough evidence. I think they will require verification form an independent trial (not associated with Biotron). Frankly the results obtained from the second trial seem almost too good to be true. All the mice dying on day 8 seems more Hollywood than real life.
- Forums
- ASX - By Stock
- BIT
- FDA application made for fast track for COVID-19
FDA application made for fast track for COVID-19, page-170
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.002(8.00%) |
Mkt cap ! $24.36M |
Open | High | Low | Value | Volume |
2.6¢ | 2.8¢ | 2.5¢ | $23.28K | 893.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15384 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 396594 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 114733 | 0.025 |
1 | 41000 | 0.024 |
2 | 153913 | 0.023 |
5 | 4245555 | 0.022 |
1 | 250000 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 396594 | 2 |
0.029 | 305600 | 3 |
0.030 | 87636 | 3 |
0.031 | 109129 | 2 |
0.032 | 500000 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
BIT (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online